Research programme: cyclo-oxygenase-2 inhibitors - NitroMed

Drug Profile

Research programme: cyclo-oxygenase-2 inhibitors - NitroMed

Alternative Names: COX-2 inhibitors research programme - NitroMed; Cyclo-oxygenase-2 inhibitors research programme - NitroMed; Research programme: COX-2 inhibitors - NitroMed

Latest Information Update: 19 Mar 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NitroMed
  • Class Pyrazoles
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Inflammation; Pain

Most Recent Events

  • 19 Mar 2008 Discontinued - Preclinical for Pain in USA (unspecified route)
  • 06 Mar 2008 Discontinued - Preclinical for Inflammation in USA (unspecified route)
  • 30 Mar 2005 Data presented at the 229th American Chemical Society National Meeting (229th-ACS-2005) have been added to the Inflammation pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top